Family touched by cancer invests in research and patient wellness initiatives at MD Anderson
“Arlene Holden’s family knows all too well that cancer touches everyone. Over the past two decades, Arlene’s daughters, Gayle Kuoni and Lerryn Carl, both faced their cancer diagnoses. For Gayle, treatment was effective and gave her a positive outcome, but for Lerryn, there was devastatingly little that could be done.”

Research trial leads to new standard in lung cancer surgery
“Thoracic surgeons at Surrey Memorial Hospital participate in an international multi-center randomized clinical trial for lung cancer surgery.”

Why Early Detection of Lung Cancer is So Important
“CHICAGO — Lung cancer is the leading cause of cancer death in the United States. While early detection can vastly improve a patient’s chances to lead a full and healthy life, the majority of those who are high-risk are not getting screened.”

Research identifies potential to improve lung cancer survival rates through therapy choices
“While Immune Checkpoint Inhibitor (ICI) immunotherapy drugs have transformed the treatment of many cancers, some lung cancer patients experience hyperprogression—a paradoxical rapid acceleration of tumor growth—after the treatment begins.”

Patients With Poor-Prognosis Metastatic NSCLC Benefit From Nivolumab and Ipilimumab
“Treatment with the immunotherapy combination of nivolumab (Opdivo) and ipilimumab (Yervoy) led to clinically meaningful overall survival (OS) results at 3 years as well as a manageable toxicity profile in special populations of patients with metastatic non–small cell lung cancer (NSCLC) in the phase 3b CheckMate 817 trial (NCT02869789).”

Depression in NSCLC is a Key Indicator of Outcomes
““Depression levels may be as important or even more important than other factors that have been associated with how people fare with lung cancer,” says Barbara Andersen, Ph.D., professor of psychology at The Ohio State University and lead author of a study that found moderate to severe depression “reliably” predicted outcomes.”

LUCAS to offer lung cancer screening in Wayne, Grantsville, and Elkins
“MORGANTOWN, WV (LOOTPRESS) – LUCAS, a first of its kind, state-of-the-art mobile lung cancer screening unit, will visit Wayne, Calhoun, and Randolph counties offering low-dose computed tomography (LDCT) scans.”

Sublobar Resection for Lung Cancer Can Be Safe in Patients With IPF and UIP
“Sublobar resection for lung cancer in patients with usual interstitial pneumonia was associated with reduced risk for postoperative acute exacerbations.”

First Double-Lung Transplants in Advanced Lung Cancer
“Double lung transplant isn’t new; in fact, it’s more common than single lung transplant. But recently surgeons at Northwestern Medicine in Chicago crossed a frontier in the lung transplantation. Two patients with stage 4 lung cancer, Albert Khoury and Tannaz Ameli, are alive and well after successful double transplantation.”


Overview of Available Therapies for EGFR Mutations in Lung Cancer
“Mark A. Socinski, MD, a medical oncologist and executive director (thoracic cancer) at the AdventHealth Cancer Institute, discusses types of EGFR mutations in non–small cell lung cancer (NSCLC) and the treatments that target these mutations.”

Key Decisionmaking Factors in Resectable Non–Small Cell Lung Cancer

Overview of Real-World Comparative Data for Amivantamab in NSCLC
“Joshua K. Sabari, MD, and Helena A. Yu, MD, discuss real-world data comparing amivantamab with other therapies in EGFR exon 20–mutated non–small cell lung cancer.